MENU
STOK
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Stoke Therapeutics (STOK) Ownership - Who owns Stoke Therapeutics?
Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine... Show more
Profile
Industry
N/A
Address
45 Wiggins Avenue
Phone
+1 781 430-8200
Employees
110
Web
https://www.stoketherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
628.41M
P/E Ratio
14.04
Total Cash
357.32M
Projected Growth
N/A
Total Debt
2.35M
Revenue
190.91M
Risk (Beta)
1.09
Dividend Yield
N/A
Total Cash/Share
6.54
Total Debt/Equity
N/A
Revenue/Share
3.33 USD as % of share price
Fundamentals
STOK
Capitalization
628M
P/E Ratio
14.04
Risk (Beta)
1.09
Dividend Yield
N/A
Total Cash
357M
Total Cash/Share
6.54
Total Debt
2.35M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
3.33%
Revenue
191M
ROE
N/A
Book Value
350M
P/B Ratio
1.80
Cash Flow
N/A
Earnings
0.87
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
8.41
Current Revenue Per Employee
1238820.20
Dividends Per Share - Security
N/A
EBITDA
40.3M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
16.43
Shares Held By Institutions
534M
Shares Outstanding - Current
54.6M
Total Liabilities
56.8M
Total Volume MTD
N/A
Value
N/A
Gain YTD
5.077
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company, which engages in the research and development of treatments for genetic diseases.
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
45 Wiggins Avenue
Phone
+1 781 430-8200
Employees
110
Web
https://www.stoketherapeutics.com